# Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds

> **NCT05607979** · PHASE2,PHASE3 · COMPLETED · sponsor: **Lavior Pharma Inc.** · enrollment: 75 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** Lavior Diabetic Wound Gel
- **DRUG:** Smith & Nephew Solosite Gel Hydrogel Wound Dressing

## Key facts

- **NCT ID:** NCT05607979
- **Lead sponsor:** Lavior Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-15
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05607979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05607979, "Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05607979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*